undamentalytics Newsletter
Sign in

Bioceres Crop Solutions Corp. (BIOX) stock

Add to watchlist

Add holding +

NASDAQ: BIOX Nasdaq Fertilizers & Agricultural Chemicals Next results ~November 12, 2026

C+ Fundamentals grade

Bioceres Crop Solutions Corp. is a US-listed company in the fertilizers & agricultural chemicals industry. Its financial year ends in June.

Stock price today

Loading chart…

Third-party market data · may be delayed

Fair value per share

Under review: every model's value for Bioceres Crop Solutions Corp. is far from the share price, which usually points to a data problem (a merger, a share-count change, a one-off) rather than a bargain or a bubble.

Price vs value

Under review: noncontrolling ownership requires a separate cash-flow valuation. We'll show the comparison once resolved.

Bioceres Crop Solutions Corp. valuation: adjust assumptions and compare models →

Who’s trading

What company insiders, investment funds and members of Congress have been doing with the stock, from their own filings.

  • Funds9 adding, 12 cuttingOf 2 active managers that changed their stake, 0 added; quarter to June 30, 2026Fund buyers and sellers

Value diary

Our note on each quarter Bioceres Crop Solutions files

Where Bioceres Crop Solutions stands after its latest Filing

Revenue for the twelve months was $238m, down 17.7% on a year earlier, a smaller fall than the 31.2% decline a quarter earlier. That puts it 9 of 11 for growth among the fertilizers & agricultural chemicals companies we cover. Free-cash-flow margin rose to 27.3% from -6.3% a year earlier. Operating margin narrowed to -9.8% from 11.9%. Against its peers on growth, profitability, cash generation and balance sheet, it grades C+. It passes 2 of our 6 financial-health checks.

Our model value for Bioceres Crop Solutions is under review, so past values are not shown until it is resolved.

Written from the company's filings and our models when each quarter's report arrives. Figures in older notes are as published at the time. Not investment advice.

The Fundamentalytics view

Next results ~November 12, 2026 (estimated)

Bioceres Crop Solutions Corp.'s trailing-twelve-month revenue fell 17.7% year on year, with a free-cash-flow margin of 27.3%. Where it stands out: free-cash-flow margin of 27.3% ranks 1 of 11 fertilizers & agricultural chemicals companies we cover. Where it lags: net margin of -110.8% ranks 10 of 11 fertilizers & agricultural chemicals companies we cover.

Current signal Free cash flow diverging from earnings: TTM free cash flow grew 45.2% while net income fell 376.3%: a 422pp divergence.

Assembled from SEC-filed figures — the full workings are on this page and in our methodology. Observations, not recommendations.

Highlights

How we pick these

Strengths

  • Strong cash generation. 27.3% of revenue turned into free cash flow, against a median of 7.4% for fertilizers & agricultural chemicals companies we cover.

Things to watch

  • Revenue shrinking. Revenue fell 17.7% over the last 12 months.
  • Loss-making. Operating margin is -9.8%: costs exceed revenue.
  • Margins narrowing. Operating margin is down 12.1 points on a year ago.
  • Missing expectations. Earnings per share fell short of the consensus estimate in 4 of the last four quarters.

Latest results

Earnings per share
-$0.14 against an average estimate of -$0.05: missed by 183.0%
Next report
November 12, 2026

Bioceres Crop Solutions' figures from its SEC filings and results release; estimates are the analysts' average. Not a recommendation.

Price chart

  • 1 day+6.7%
  • 1 week+9.4%

Closing prices to 2026-11-02. Price change only, dividends excluded.

Loading chart…

Third-party market data · may be delayed

At a glance

Trailing twelve months, from SEC filings

Profitability

Revenue (TTM)
$238M
Operating margin
-9.8%
Net margin
-110.8%
EPS (TTM, diluted)
$-4.15

Growth

Revenue growth
−17.7%
Change in growth rate
+13.5 pts
Share count change
+0.7%

Cash

Free cash flow (TTM)
$65M
FCF margin
27.3%
Stock pay % of revenue
0.1%

News & updates

Updated November 2, 2026

Company announcements, filed results and changes that matter to shareholders.

No recent updates are available for BIOX from the sources we follow. See filings →

Refreshed hourly when new source data is available. Summaries are checked against company releases and SEC filings. Company announcement headlines are labelled when a checked summary is unavailable.

Valuation

Bioceres Crop Solutions Corp. valuation models and calculator

Fundamentalytics rating

model v1.6 · 2026-11-03

Not rated: noncontrolling ownership requires a separate cash-flow valuation.

The inputs used by the models below have passed source checks. Individual model values are available below and in the interactive valuator. Their differences are shown explicitly; the platform combined value and recommendation remain withheld.

Valuation models

We value Bioceres Crop Solutions Corp. as an operating company, with every model that fits that kind of business. Cost of equity 7.9%: the 10-year Treasury yield (4.9%) plus a beta of 0.65 times a 4.5% equity risk premium.

Value per share by model
Model Value per share In the combined value?
Price-to-earnings vs peers Earnings per share times peers' typical (harmonic-mean) price-to-earnings. — Does not apply: This model is withheld pending its input or assumption review.
Residual income Book value plus the present value of returns above the cost of equity, fading over ten years. — Does not apply: This model is withheld pending its input or assumption review.
Justified price-to-book Book value times (return on equity - growth) / (cost of equity - growth): steady-state returns. — Does not apply: This model is withheld pending its input or assumption review.
Price-to-sales vs peers Sales per share times peers' typical price-to-sales; used only when earnings are negative. ~$1.3 ~$1.7–$4.6 Left out: out of range vs price (5.81x)
Cash-flow model (DCF) Free cash flow after stock pay, grown then faded to 2.5%, discounted at 8.5%. — Does not apply: This model is withheld pending its input or assumption review.
Growth cash-flow model Revenue for this year and next from analysts' consensus, then growth fading to 2.5%; the operating margin moving to profitable peers'; investment needed per dollar of growth from peers; reduced by a failure probability. For young or fast-growing companies. The starting margin is normalized to between -100% and 60%; net margin is a proxy when operating income is not tagged. Uses analysts' consensus estimates (third-party data), not our forecasts. — Does not apply: This model is withheld pending its input or assumption review.
Revenue-to-maturity model Revenue grown to maturity with the cash margin moving to the industry's; for companies not yet profitable. — Does not apply: This model is withheld pending its input or assumption review.
Combined value Individual source-checked model scenarios are available. The platform combined value and recommendation remain withheld. — Combined value withheld. Review the individual models and their assumptions.

Different models fail in different ways, so where several apply we average them rather than trust one. Peer-based models compare Bioceres Crop Solutions Corp. with Fertilizers & Agricultural Chemicals in our coverage, using third-party market data. Model values are estimates under stated assumptions, updated as new filings arrive; not price targets or investment advice. How each model works.

Moat

Not assessed: fewer than five years of comparable figures in the filings. AI disruption exposure for this industry: Low.

A rules-based reading of reported figures, not a forecast and not investment advice. How the score is built: methodology.

Forecasts and guidance

Next results: November 12, 2026, after the close.

Analysts' consensus

No analyst estimates are published for Bioceres Crop Solutions Corp.: too few analysts cover it.

Earnings against estimates

Quarter toEstimateActualSurprise
Mar 2026 −$0.05 −$0.14 −183.0%
Dec 2025 $0.07 −$0.08 −213.6%
Sept 2025 −$0.09 −$0.12 −34.7%
Jun 2025 $0.10 −$0.70 −837.8%

Adjusted EPS as companies report it, against the average analyst estimate.

Positioning

Short interest
1.6%
of tradable shares
Days to cover
3.51
at average volume
Short interest, 1 month
+88%
to October 15, 2026
Held by institutions
23%
of shares
Held by insiders
17.0%
of shares

Consensus figures average analysts' published estimates (third-party data); guidance is the company's own. Neither is our forecast. Short interest is reported twice a month and lags. Market data may be delayed.

This section is general information, not investment advice or a personal recommendation, and it does not take account of your objectives or circumstances. Forecasts and guidance are estimates, not promises: companies miss their own guidance and analysts' figures are often revised. Prices can fall as well as rise, and you can lose money. See our disclaimer.

Share-price performance

Market data may be delayed

Recent prices are available. Older price history and the statistics that need it are being loaded in the background.

Price behaviour

52-week range
Not enough history
From 52-week high
—
vs 50-day average
—
vs 200-day average
—
Volatility (1 year)
—
Beta vs S&P 500
—

Volatility is the annualised standard deviation of daily returns. Beta 1.5 means the shares typically moved 1.5% for each 1% move in the S&P 500 over the past year. Prices to November 2, 2026.

Bioceres Crop Solutions Corp. in five measures

Fundamentals grade C+
Growth Profitability Cash Balance sheet

Growth, profitability, cash generation and balance sheet are percentiles against the companies we cover in the same industry, from SEC filings (100 = best). Value compares the share price with our modelled value range (50 = at our base value; higher = cheaper). A description of reported data and our model — not a quality score or advice.

Fundamentals

Revenue (TTM) Bioceres Crop Solutions Corp.
$0 $200M $400M $600M FY17 Q2 FY19 Q4 FY21 Q4 FY23 Q4 FY26 Q4 Revenue (TTM), FY17 Q2: $41.2M Revenue (TTM), FY18 Q4: $133.5M Revenue (TTM), FY19 Q4: $160.6M Revenue (TTM), FY20 Q4: $173.1M Revenue (TTM), FY21 Q4: $209.5M Revenue (TTM), FY22 Q4: $334.8M Revenue (TTM), FY23 Q4: $420.1M Revenue (TTM), FY24 Q4: $420.4M Revenue (TTM), FY25 Q4: $289.4M Revenue (TTM), FY26 Q4: $238.3M $238.3M

Source: SEC EDGAR filings. Retrieved November 3, 2026.

View chart data
Period Revenue (TTM)
FY17 Q2 $41.2M
FY18 Q4 $133.5M
FY19 Q4 $160.6M
FY20 Q4 $173.1M
FY21 Q4 $209.5M
FY22 Q4 $334.8M
FY23 Q4 $420.1M
FY24 Q4 $420.4M
FY25 Q4 $289.4M
FY26 Q4 $238.3M
Revenue growth, TTM YoY Bioceres Crop Solutions Corp.
-50% 0% 50% 100% FY19 Q4 FY21 Q4 FY23 Q4 FY26 Q4 Revenue growth, TTM YoY, FY19 Q4: 20.3% Revenue growth, TTM YoY, FY20 Q4: 7.8% Revenue growth, TTM YoY, FY21 Q4: 21.0% Revenue growth, TTM YoY, FY22 Q4: 59.8% Revenue growth, TTM YoY, FY23 Q4: 25.4% Revenue growth, TTM YoY, FY24 Q4: 0.1% Revenue growth, TTM YoY, FY25 Q4: -31.2% Revenue growth, TTM YoY, FY26 Q4: -17.7% -17.7%

Source: SEC EDGAR filings. Retrieved November 3, 2026.

View chart data
Period Revenue growth, TTM YoY
FY19 Q4 20.3%
FY20 Q4 7.8%
FY21 Q4 21.0%
FY22 Q4 59.8%
FY23 Q4 25.4%
FY24 Q4 0.1%
FY25 Q4 -31.2%
FY26 Q4 -17.7%
Operating margin (TTM) Bioceres Crop Solutions Corp.
-10% 0% 10% 20% 30% FY17 Q2 FY19 Q4 FY21 Q4 FY23 Q4 FY26 Q4 Operating margin (TTM), FY17 Q2: 0.5% Operating margin (TTM), FY18 Q4: 11.8% Operating margin (TTM), FY19 Q4: 20.0% Operating margin (TTM), FY20 Q4: 22.6% Operating margin (TTM), FY21 Q4: 18.3% Operating margin (TTM), FY22 Q4: 11.9% Operating margin (TTM), FY23 Q4: 12.9% Operating margin (TTM), FY24 Q4: 12.4% Operating margin (TTM), FY25 Q4: 2.3% Operating margin (TTM), FY26 Q4: -9.8% -9.8%

Source: SEC EDGAR filings. Retrieved November 3, 2026.

View chart data
Period Operating margin (TTM)
FY17 Q2 0.5%
FY18 Q4 11.8%
FY19 Q4 20.0%
FY20 Q4 22.6%
FY21 Q4 18.3%
FY22 Q4 11.9%
FY23 Q4 12.9%
FY24 Q4 12.4%
FY25 Q4 2.3%
FY26 Q4 -9.8%
FCF margin (TTM) Bioceres Crop Solutions Corp.
-10% 0% 10% 20% 30% FY17 Q2 FY19 Q4 FY21 Q4 FY23 Q4 FY26 Q4 FCF margin (TTM), FY17 Q2: -4.4% FCF margin (TTM), FY18 Q4: 11.7% FCF margin (TTM), FY19 Q4: 17.2% FCF margin (TTM), FY20 Q4: 4.4% FCF margin (TTM), FY21 Q4: -4.3% FCF margin (TTM), FY22 Q4: -6.3% FCF margin (TTM), FY23 Q4: -2.1% FCF margin (TTM), FY24 Q4: 7.9% FCF margin (TTM), FY25 Q4: 15.5% FCF margin (TTM), FY26 Q4: 27.3% 27.3%

Source: SEC EDGAR filings. Retrieved November 3, 2026.

View chart data
Period FCF margin (TTM)
FY17 Q2 -4.4%
FY18 Q4 11.7%
FY19 Q4 17.2%
FY20 Q4 4.4%
FY21 Q4 -4.3%
FY22 Q4 -6.3%
FY23 Q4 -2.1%
FY24 Q4 7.9%
FY25 Q4 15.5%
FY26 Q4 27.3%

Data: SEC EDGAR XBRL company facts (as filed in 10-K/10-Q); forms 20-F. Generated November 3, 2026. Definitions in our methodology.

Financial statements

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year 2017 Dec 2016 2018 Jun 2018 2019 Jun 2019 2020 Jun 2020 2021 Jun 2021 2022 Jun 2022 2023 Jun 2023 2024 Jun 2024 2025 Jun 2025 2026 Jun 2026
Income
Revenue 41 134 161 173 210 335 420 420 289 238
Gross profit 11 56 74 80 91 126 185 157 105 83
Operating income 0 16 32 39 38 40 54 52 7 −23
Net income −6 −11 −18 3 −7 −7 19 4 −55 −264
Diluted EPS −$0.21 −$0.39 −$0.60 $0.09 −$0.18 −$0.17 $0.30 $0.07 −$0.88 −$4.06
Growth (year on year)
Revenue — +224.4% +20.3% +7.8% +21.0% +59.8% +25.4% +0.1% −31.2% −17.7%
Operating income — — +104.2% +22.0% −1.9% +3.9% +35.9% −3.8% −87.3% −454.8%
Net income — — — — — — — −77.2% — —
Diluted EPS — — — — — — — −77.4% — —
Margins
Gross margin 25.7% 42.3% 45.9% 45.9% 43.4% 37.8% 43.9% 37.4% 36.3% 34.9%
Operating margin 0.5% 11.8% 20.0% 22.6% 18.3% 11.9% 12.9% 12.4% 2.3% −9.8%
Net margin −14.2% −8.3% −11.4% 1.9% −3.3% −2.2% 4.5% 1.0% −19.1% −110.8%
Free-cash-flow margin −4.4% 11.7% 17.2% 4.4% −4.3% −6.3% −2.1% 7.9% 15.5% 27.3%
Cash flow
Cash from operations −1 18 30 9 −6 −18 3 42 50 66
Capital spending 1 3 2 2 3 3 11 8 5 1
Free cash flow −2 16 28 8 −9 −21 −9 33 45 65
Stock-based pay — 0 −0 3 2 1 3 13 4 0
Free cash flow after stock pay — 16 28 4 −11 −22 −12 20 41 65
Balance sheet
Cash — 2 3 43 36 33 48 44 33 11
Total debt — 91 112 123 163 207 218 204 184 146
Net debt (negative = net cash) — 89 108 81 127 173 170 159 151 134
Diluted shares 28m 28m 30m 36m 39m 42m 63m 63m 63m 64m
Returned to shareholders
Dividends 0 — — — — — 0 0 0 —
Buybacks — — — 0 4 — 3 1 1 —
Total returned 0 — — 0 4 — 3 1 1 —

Source: SEC EDGAR XBRL company facts (US and foreign periodic filings); column headings link to the filing. EBITDA is operating income plus depreciation and amortisation. Free cash flow is cash from operations minus capital spending. Growth is left blank when last year's figure was a loss or under 2% of revenue. Share counts and EPS are restated for stock splits. A dash means the company didn't report the figure.

Financial health

2 of 6 checks passed · June 30, 2026
What it owns · $448m
Short-term assets $215mLonger-term assets $233m
What it owes, and who funded it · $425m
Short-term liabilities $270mLonger-term liabilities $144mShareholders' equity $11m
  • Short-term assets cover short-term liabilities $215m of assets due within a year against $270m of liabilities due within a year.
  • Short-term assets cover long-term liabilities $215m short-term assets against $144m of longer-dated liabilities.
  • More cash than debt $11m of cash against $146m of debt.
  • Debt below 40% of shareholders' equity Debt is 1359% of equity.
  • Debt burden no higher than five years ago Debt to equity moved from 127% to 1359% over five years.
  • A year's operating cash flow covers at least 20% of debt $66m of operating cash flow against $146m of debt.
  • Operating profit covers interest at least five times over Interest not separately reported. Not assessable.

From Bioceres Crop Solutions Corp.'s latest balance sheet as filed. Checks are fixed, documented rules (methodology), counted only where the company reports the figures — a dot means the filing doesn't break the item out. Descriptions of reported data, not advice.

Dividends, buybacks and capital spending

FY2025 Q4 TTM
Buybacks (TTM)
$926,899
Dividends (TTM)
$72,051
Returned to shareholders
2%
of free cash flow
Buybacks, last 3 fiscal years
$4.7M
Diluted share count
+0.7%
year over year
Total shareholder yield
7.1%
dividends 0.5% + buybacks 6.6% of market value
R&D spending
4.6%
of revenue

Competitors: side by side with peers

Closest by revenue in fertilizers & agricultural chemicals
Last 12 months unless stated BIOX AVD UAN FMC SMG SEED Median
Revenue, last 12 months $238m $510m $677m $2.8bn $3.5bn $13m $3.5bn
Revenue growth, last 12 months −17.7% −3.5% 17.5% −22.0% 4.6% −19.6% 3.7%
Revenue growth, 3-year average — −3.6% −4.5% −17.2% −1.7% −45.4% −4.2%
Revenue growth, latest quarter — −9.7% 20.0% −80.5% 1.1% — −1.2%
Gross margin 34.9% 29.4% 33.5% 22.0% 31.8% 7.0% 31.0%
Operating margin −9.8% −5.2% 28.1% −97.0% 11.0% <−999% 3.4%
Operating margin, 3-year average 4.6% −7.2% 21.1% −29.8% 6.8% — 6.8%
Net margin −110.8% −10.7% 23.7% −151.2% 2.1% −58.4% 2.1%
Cash from operations / revenue 27.7% −8.2% 31.3% 15.1% 10.6% −25.0% 14.8%
Free-cash-flow margin 27.3% −9.2% 21.4% 13.1% 7.6% −37.3% 7.4%
Free-cash-flow margin, 3-year average 10.9% −3.7% 19.8% 5.8% 14.4% <−999% 9.1%
Stock pay / revenue 0.1% 0.3% 1.3% 0.9% 1.4% 25.3% 0.6%
Change in share count 0.7% 1.5% 0.0% 1.5% 3.2% 15.9% 0.1%

Median of all 11 companies we cover in fertilizers & agricultural chemicals. Shaded: best of the six on that line (lowest for stock pay and share-count growth). 3-year figures average the last three 12-month periods; 3-year growth is compound annual. Source: SEC filings.

Peer comparison

11 fertilizers & agricultural chemicals companies
Measure Company Peer median Rank
Revenue growth Growth -17.7% 3.7% 9 of 11
Change in growth rate Growth +13.5pp -0.8pp 3 of 11
Gross margin Profitability 34.9% 31.0% 3 of 11
Operating margin Profitability -9.8% 8.1% 8 of 9
Net margin Profitability -110.8% 2.1% 10 of 11
Free-cash-flow margin Cash generation 27.3% 7.4% 1 of 11
Stock pay as % of revenue Cash generation 0.1% 0.6% 1 of 9
Long-term debt as % of assets Balance sheet 21.9% 21.3% 7 of 11
Change in share count Balance sheet 0.7% 0.1% 7 of 11

Rank 1 = best in the group (for spending, debt and dilution, lower ranks first).

Who owns it

Funds buying and selling
Reported value
$2.9M
Institutions reporting
27
Shares held vs prior quarter
▼ 8.9%
Positions opened / closed
3 / 6

Top buyers and sellers, Q2 2026: 9 institutions bought and 12 sold ; the biggest buyer was Mirae Asset Global Etfs Holdings Ltd (+333K shares) and the biggest seller Marshall Wace, LLP (−702K). See which funds bought and sold →

Largest reported holders, June 30, 2026
Manager Value Shares Share of 13F value Shares QoQ
Solel Partners LP $1.6M 4.6M 54.4% 0.0%
Mirae Asset Global Etfs Holdings Ltd. $492,319 1.4M 16.7% ▲ 31.0%
Long Focus Capital Management, LLC $290,495 830K 9.9% 0.0%
Ardsley Advisory Partners LP $166,298 475K 5.6% 0.0%
UBS Group AG $142,897 408K 4.8% ▲ 14.0%
Susquehanna International Group, LLP $74,547 213K 2.5% ▼ 1.1%
PNC Financial Services Group, Inc. $46,550 133K 1.6% 0.0%
Goldman Sachs Group Inc $45,319 129K 1.5% ▲ 10.8%
Ping Capital Management, Inc. $19,256 55K 0.7% 0.0%
Jane Street Group, LLC $12,697 36K 0.4% ▲ 6.3%
Two Sigma Investments, LP $10,512 30K 0.4% ▼ 68.5%
Stifel Financial Corp $10,360 30K 0.4% ▼ 64.4%

From Form 13F filings with the SEC ( quarterly data sets), as reported by each manager for June 30, 2026 and filed up to 45 days later. 13F reports cover long US-listed positions of managers above $100M only, so this is not Bioceres Crop Solutions Corp.'s complete shareholder register. Values are as reported by the filers .

Insider trading activity

Full insider history and chart
Insider purchases History → $0 0 trades by 0 insiders, last 12 months Insider sales History → $0 0 trades by 0 insiders
Net ▲ $0 net buying

No open-market insider trades reported in the last 12 months.

From insiders' Form 4 filings with the SEC. Excludes awards, option exercises and shares withheld for tax. "Pre-set plan" means the filing marks the trade as made under a Rule 10b5-1 plan. See every insider trade since five years ago, on a price chart.

Earnings dates and SEC filings

Results announcements

Recent SEC filings

Data status

When each part of this page on Bioceres Crop Solutions Corp. was last updated.

DataLast updatedSource
Share priceExchange closing prices
News and updatesCompany releases and SEC 8-K filings
Analyst estimatesAggregated analyst estimates
Valuation and scoresOur models, from the filed figures

How we build and check these figures: methodology and data sources.

Bioceres Crop Solutions Corp. in brief

What does Bioceres Crop Solutions Corp. do?
Bioceres Crop Solutions Corp. is a US-listed company in the fertilizers & agricultural chemicals industry. Its financial year ends in June.
What is Bioceres Crop Solutions Corp.'s stock ticker?
Bioceres Crop Solutions Corp. trades under the ticker BIOX on Nasdaq. This page brings together its financial statements, valuation models, ownership and recent company updates.
What is Bioceres Crop Solutions Corp.'s revenue, and how fast is it growing?
Over its most recent trailing twelve months, Bioceres Crop Solutions Corp. reported revenue of $238M, 17.7% lower than a year earlier, according to its SEC filings.
What is Bioceres Crop Solutions Corp.'s free cash flow?
Bioceres Crop Solutions Corp.'s free-cash-flow margin is 27.3% of revenue over the trailing twelve months, ranking 1 of the 11 fertilizers & agricultural chemicals companies we cover.
Who are Bioceres Crop Solutions Corp.'s largest institutional shareholders?
By value reported in 13F filings for June 30, 2026, the largest reported holders are Solel Partners LP, Mirae Asset Global Etfs Holdings Ltd. and Long Focus Capital Management, LLC. 13F reports cover long US-listed positions of managers above $100M, filed up to 45 days after quarter end.
Is Bioceres Crop Solutions Corp. buying back stock, and does it pay a dividend?
Bioceres Crop Solutions Corp. spent $926,899 on share repurchases over the trailing twelve months, and its diluted share count still rose 0.7% over the year.
Does Bioceres Crop Solutions Corp. pay a dividend?
Yes: Bioceres Crop Solutions Corp. paid $72,051 in dividends over the trailing twelve months, a dividend yield of 0.51%.
How much debt does Bioceres Crop Solutions Corp. have?
Bioceres Crop Solutions Corp.'s debt-to-equity ratio is 1358.6%, from its latest balance sheet (126.7% five years earlier). The financial health section below sets out its other solvency checks.
Who are Bioceres Crop Solutions Corp.'s competitors?
In our Fertilizers & Agricultural Chemicals peer group, the companies closest to Bioceres Crop Solutions Corp. are American Vanguard Corp, CVR Partners, LP, FMC Corp, Scotts Miracle-gro Co and Origin Agritech LTD. The side-by-side comparison below sets their revenue, margins and growth against Bioceres Crop Solutions Corp.'s.
When is Bioceres Crop Solutions Corp.'s next earnings date?
Around November 12, 2026, estimated from the spacing of its past results announcements (8-K filings). That is an estimate, not a confirmed date — Bioceres Crop Solutions Corp. announces its own schedule.